IRS
IPXL

Invictus RG (Singapore)’s Impax Laboratories, Inc. IPXL Stock Holding History

Invictus RG (Singapore)’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-456
Closed -$16K – 526
2015
Q3 		$16K Buy
+456
New +$20.5K 0.01% 508
2014
Q4 		– Sell
-268
Closed -$6K – 768
2014
Q3 		$6K Sell
268
-1,938
-88% -$49.6K 0.01% 625
2014
Q2 		$66K Sell
2,206
-4,358
-66% -$118K 0.07% 361
2014
Q1 		$173K Sell
6,564
-10,861
-62% -$271K 0.21% 192
2013
Q4 		$438K Buy
17,425
+385
+2% +$8.59K 0.3% 110
2013
Q3 		$349K Buy
+17,040
New +$352K 0.3% 135

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Invictus RG (Singapore)'s IPXL Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 456 shares — an estimated $16K sold.

Invictus RG (Singapore) first reported a position in IPXL in Q3 2013 and held it in 6 quarters. The position peaked at $438K in Q4 2013. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 456 Impax Laboratories, Inc. shares in Q4 2015, an estimated $16K.
  • Invictus RG (Singapore) first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 6 quarters.
  • Invictus RG (Singapore)'s Impax Laboratories, Inc. position peaked at $438K in Q4 2013.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.